Talzenna
NDC 0069-1195, talazoparib, capsule, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-1195
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211651
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TALAZOPARIB TOSYLATE1 mg/1
Pharmacologic classes
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-1195-30 | 00069119530 | 1 BOTTLE in 1 CARTON (0069-1195-30) / 30 CAPSULE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f2423edd-6d24-495c-aec1-c2f457f08d9a
Use it
Look up 0069-1195 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-1195 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-1195. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.